Pharmacology of BMN 250 administered via intracerebroventricular infusion once every 2 weeks for twenty-six weeks or longer in a canine model of mucopolysaccharidosis type IIIBN. Matthew Ellinwood,Bethann Valentine,Andrew Hess,Jackie K. Jens,Elizabeth M. Snella,Wendy A. Ware,Shannon J. Hostetter,Gil Ben-Shlomo,Nick D. Jeffery,Sina Safayi,Jodi D. Smith,Suzanne T. Millman,Rebecca L. Parsons,Mark Butt,Jonathan D. Cooper,Igor Nestrasil,Heather Prill,Xiao Liu,Huiyu Zhou,Roger Lawrence,Brett E. Crawford,Anita Grover,Andrew Melton,Anu Cherukuri,Jill C.M. Wait,Jason Pinkstaff,Emma McCullaghMolecular Genetics and Metabolism（2018）引用 5|浏览23暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
